News September 16, 2025
Clinical data shows that BrainsWay’s new accelerated stimulation protocol is comparable to standard...
News August 21, 2025
This investment marks BrainsWay’s entrance into the market for mental health therapies that can be...
News August 20, 2025
The Investment is part of BrainsWay’s ongoing strategy to acquire minority positions in leading U.S....
Events June 12 - June 14, 2025
BrainsWay is attending the CTMSS conference June 13th through June 14th, in San Diego, CA. We invite...
Events May 9 - May 14, 2025
BrainsWay is attending the International Neuromodulation Society conference from May 9th through May...
Events May 28 - May 30, 2025
BrainsWay is attending the Psych Congress Elevate Providers conference from May 28th through May 30th...
In the media September 17, 2025
BrainsWay (Nasdaq:BWAY) today announced the FDA granted expanded clearance for its Deep Transcranial...
In the media September 9, 2025
Concerns about youth screen use continue to grow, with research linking addictive engagement with social...
In the media September 4, 2025
Recent reporting from GPB highlights how Transcranial Magnetic Stimulation (TMS) is offering hope for...
